Cathepsin D Monoclonal antibody proteintech 66534-1-Ig

$449.00
In stock
SKU
66534-1-Ig

 

CTSD, 2F6F7, Cathepsin D heavy chain, Cathepsin D light chain, CLN10

Host / Isotype: Mouse / IgG2b Class: Monoclonal
Reactivity: Human And More (1) Immunogen: CatNo: Ag15254 Product name: Recombinant human Cathepsin D protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 59-412 aa of BC016320 Sequence: VPAVTEGPIPEVLKNYMDAQYYGEIGIGTPPQCFTVVFDTGSSNLWVPSIHCKLLDIACWIHHKYNSDKSSTYVKNGTSFDIHYGSGSLSGYLSQDTVSVPCQSASSASALGGVKVERQVFGEATKQPGITFIAAKFDGILGMAYPRISVNNVLPVFDNLMQQKLVDQNIFSFYLSRDPDAQPGGELMLGGTDSKYYKGSLSYLNVTRKAYWQVHLDQVEVASGLTLCKEGCEAIVDTGTSLMVGPVDEVRELQKAIGAVPLIQGEYMIPCEKVSTLPAITLKLGGKGYKLSPEDYTLKVSQAGKTLCLSGFMGMDIPPPSGPLWILGDVFIGRYYTVFDRDNNRVGFAEAARL Predict reactive species
 Applications: WB, IHC, IF/ICC, FC (Intra), ELISA Observed Molecular Weight: 412 aa, 45 kDa
Formulation: PBS, Azide, Glycerol GenBank Accession Number: BC016320
Conjugate: Unconjugated Gene Symbol: Cathepsin D
Tested Applications: Positive WB detected in Gene ID (NCBI): 1509
Application: Western Blot (WB) RRID: AB_2881897
Dilution: WB : 1:5000-1:50000 Conjugate: Unconjugated
Tested Reactivity: Human Form: Liquid
Host / Isotype: Mouse / IgG2b Background Information: CTSD (Cathepsin D) also named CPSD, belongs to the peptidase A1 family. It is ubiquitously expressed and is involved in proteolytic degradation, cell invasion, and apoptosis. Human CTSD is synthesized as a 52-kDa precursor that is converted into an active 48-kDa single-chain intermediate in the endosomes, and then into a fully active mature form, composed of a 34-kDa heavy chain and a 14-kDa light chain, in the lysosomes. It is a lysosomal acid protease found in neutrophils and monocytes and involved in the pathogenesis of several diseases such as breast cancer and possibly Alzheimer disease (PMID: 27114232, PMID: 30717773, PMID: 30051532).

 

 

Reviews

Write Your Own Review
You're reviewing:Cathepsin D Monoclonal antibody proteintech 66534-1-Ig
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.